Have You Lost Money Investing In Spectrum Pharmaceuticals?
Securities Class Action Investigation – SPPI Investors Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) violated federal securities laws.
Spectrum investors who purchased, or otherwise acquired, the Company’s securities between December 27, 2018 and August 5, 2021, both dates inclusive (the “Class Period”), and suffered financial losses are encouraged to contact Kehoe Law Firm, P.C. to learn more about the securities investigation or potential legal claims.
Spectrum investors should be aware that a class action lawsuit was filed against Spectrum on August 31, 2021 in United States District Court, District of Nevada, on behalf of a class consisting of all persons and entities other than the Spectrum Defendants that purchased or otherwise acquired Spectrum securities between December 27, 2018 and August 5, 2021, both dates inclusive (the “Class Period”), seeking to recover damages caused by the Spectrum Defendants’ alleged violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.